Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 134 Breast Neoplasms 94 Colorectal Neoplasms 65 Carcinoma, Hepatocellular 57 Squamous Cell Carcinoma of Head and Neck 48 Stomach Neoplasms 46 Lung Neoplasms 45 Triple Negative Breast Neoplasms 43 Prostatic Neoplasms 43 Leukemia, Myeloid, Acute 43 Small Cell Lung Carcinoma 41 Uterine Cervical Neoplasms 40 Rectal Neoplasms 37 Neoplasms 31 Pancreatic Neoplasms 30 Recurrence 29 Neoplasm Metastasis 29 Esophageal Squamous Cell Carcinoma 25 Esophageal Neoplasms 24 Ovarian Neoplasms 23 Nasopharyngeal Carcinoma 21 Brain Neoplasms 21 Melanoma 20 Lymphoma, Large B-Cell, Diffuse 20 Colonic Neoplasms 20 Carcinoma, Renal Cell 20 Head and Neck Neoplasms 19 Endometrial Neoplasms 19 Multiple Myeloma 18 Biliary Tract Neoplasms 18

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × ER+HER2- Breast Cancer × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡